Solo para uso en investigación

CJC-1295 (no DAC) 10MG

$115.00¡Compre y gane 115 puntos!

CJC-1295 (no DAC) 10MG · Referencia CJCND-PW-10MG

En existencia

# comprados Precio con descuento
5 - 9 $109.25
10 + $103.50
Referencia del producto
CJCND-PW-10MG
Solo para uso en investigación de laboratorio. No es para consumo humano. No se proporciona orientación de dosificación ni de administración.

Acerca de CJC-1295 (no DAC) 10MG

MaterialCJC-1295 (no DAC) 10MG
Referencia del productoCJCND-PW-10MG

CJC-1295 (no DAC)

CJC-1295 (no DAC) is a research grade synthetic peptide developed for controlled laboratory investigation of growth hormone releasing hormone pathways. This non-DAC format allows research teams to evaluate timing dependent behavior within structured experimental windows. Because it excludes Drug Affinity Complex modification, it is often selected for study designs that prioritize tighter observation intervals, repeatable sampling, and protocol flexibility.

In RUO settings, compound selection depends on consistency, documentation, and reliable handling characteristics. Therefore, CJC-1295 (no DAC) is supplied in a lyophilized format to support stable storage prior to controlled reconstitution. When used within qualified laboratory environments, it fits well into workflows that require precise planning, clear recordkeeping, and repeatable procedures.

Estructura no-DAC para la investigación controlada de tiempo

The “no DAC” designation indicates that this peptide does not include an extended binding modification. As a result, researchers can better align experimental timing with short window data collection, comparative models, and protocol variations. Additionally, this structure supports research designs that focus on pulse style evaluation, time course comparisons, and method development for analytical measurement.

Características clave para flujos de trabajo de laboratorio

  • Péptido sintético suministrado solo para uso en investigación
  • Estructura modificada sin DAC para diseños de estudio que dependen del tiempo
  • Formato de polvo liofilizado para procedimientos controlados de reconstitución
  • Adecuado para la evaluación e investigación de laboratorio in vitro estructurada
  • Producido con procesos centrados en la calidad adecuados para la manipulación de RUO

Aplicaciones de investigación y ajuste al protocolo

CJC-1295 (no DAC) is commonly integrated into research frameworks where timing, sampling, and comparison are central. For example, laboratories may use it while developing assay methods, evaluating pathway responses, or comparing non-DAC and DAC style formats under consistent conditions. Because timing variables can materially impact study outcomes, the non-DAC structure can help align observation windows with planned collection points and analytical readouts.

Además, la presentación liofilizado apoya el control de inventario y la estandarización de la rutina de laboratorio. Esto puede simplificar los pasos de preparación cuando los equipos siguen procedimientos validados de etiquetado, documentación y reconstitución controlada. En consecuencia, los investigadores pueden mantener prácticas de manejo consistentes a través de múltiples carreras e iteraciones de protocolos.

Notas de manejo y almacenamiento

Store CJC-1295 (no DAC) in a cool, dry environment prior to reconstitution. After reconstitution, follow standard laboratory storage protocols based on your internal procedures and study requirements. Always use proper sterile technique, calibrated equipment, and appropriate documentation for each preparation step. For best consistency, maintain a controlled workflow that includes lot tra

Producto. Concentración. Lote.

Search the original archive for CJC-1295 (no DAC) 10MG. Verify the complete lot number on your label against the report.

Buscar un informe de laboratorio
Imágenes de respaldo 3 archivos

Imágenes originales adjuntas a este producto. Para el lote, la concentración y las fechas del reporte, use el archivo con búsqueda de arriba y verifique el documento en sí.

Nombre en catálogo
CJC-1295 (no DAC) 10MG
Referencia del producto
CJCND-PW-10MG
Uso previsto
Solo para investigación de laboratorio
Envíos y devoluciones
¿Necesitas un registro de producto o lote?

Incluya el nombre del producto y el número de lote al comunicarse con soporte.

Contactar a soporte

Preguntas frecuentes

CJC-1295 (no DAC) binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering intracellular signaling such as increased cyclic AMP (cAMP) that promotes endogenous growth hormone releaser pathways in research models. This receptor interaction is similar to that of endogenous GHRH but without extended systemic retention.

Without the Drug Affinity Complex (DAC), CJC-1295 (no DAC) has a shorter half-life in experimental systems compared with the DAC-modified version. This results in more pulsatile receptor activation rather than prolonged receptor engagement, which is useful in research contexts where shorter signaling bursts are studied.

Activation of the GHRH receptor by CJC-1295 (no DAC) initiates downstream pathways including cAMP/PKA signaling and subsequent peptide-linked hormone axis events. These signaling events influence patterns of growth hormone axis activity and insulin-like growth factor 1 (IGF-1) signaling in controlled research settings.

CJC-1295 (no DAC) is used in in vitro and animal studies to analyze receptor pharmacology, hormone axis activation, and gene expression changes linked to growth hormone regulator pathways. Its short signaling profile makes it a useful tool for studies of pulsatile endocrine dynamics.

CJC-1295 (no DAC) binds to GHRH receptors on somatotroph cells in the anterior pituitary, triggering intracellular signaling such as increased cyclic AMP (cAMP) that promotes endogenous growth hormone releaser pathways in research models. This receptor interaction is similar to that of endogenous GHRH but without extended systemic retention.

CJC-1295 (no DAC) is studied because its precise peptide sequence and receptor target allow researchers to dissect how growth hormone releaser signaling influences downstream biochemical networks. Its defined receptor interaction provides insight into endocrine signaling mechanisms and intracellular pathways tied to peptide-mediated hormone axis regulation.

De la colección.

ARA-290 10MG

ARA-290 10MG

$76.00¡Compre y gane 76 puntos!
Ver detalles del productoARA-PW-10MG
Selank 10MG

Selank 10MG

$55.00¡Compre y gane 55 puntos!
Ver detalles del productoSELK-PW-10MG
AOD-9604 10MG

AOD-9604 10MG

$80.00¡Compre y gane 80 puntos!
Ver detalles del productoAOD-PW-10MG
Enlarged product gallery image